Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report

Peer Review reports

Original Submission
7 Jun 2017	Submitted	Original manuscript
24 Aug 2017	Reviewed	Reviewer Report - Leonidas Grigorakos
13 Nov 2017	Author responded	Author comments - Byung Woo Yoon
Resubmission - Version 2
13 Nov 2017	Submitted	Manuscript version 2
Publishing
19 Nov 2017	Editorially accepted
20 Dec 2017	Article published	10.1186/s13256-017-1514-x

Back to article page